Related Experiment Video
Updated: May 6, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
A Retrospective Multicenter Study of Arterial Thromboembolic Events in Hospitalized COVID-19 Patients: Incidence and
David Schinz1,2, Marcel Ploch3, Andreas Saleh4
1Department of Neuroradiology, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. david.schinz@uk-erlangen.de.
Insights
COVID-19 is a systemic disease that can cause arterial thrombotic events (ATE), including stroke and heart attack. These events, often occurring within the first week of symptoms, may present with unique imaging features like free-floating clots.
Area of Science:
- Cardiology
- Neurology
- Infectious Diseases
Background:
- COVID-19 is increasingly recognized as a systemic disease impacting multiple organ systems.
- The coagulation system is significantly affected in COVID-19 patients, leading to a risk of arterial thrombotic events (ATE).
Purpose of the Study:
- To investigate the incidence and specific imaging characteristics of ATE in hospitalized COVID-19 patients.
- To analyze the localization, timing, and clinical associations of ATE in the context of COVID-19.
Main Methods:
- Retrospective screening of databases from five German tertiary care centers (January 2020 - May 2021).
- Analysis of 110 ATE cases in 102 COVID-19 patients for localization, timing, imaging features, and clinical/laboratory correlations.
Main Results:
- 3.1% of hospitalized COVID-19 patients experienced ATE, with ischemic stroke and myocardial infarction being most common.
- ATE occurred a median of four days after symptom onset, with some cases preceding symptoms.
- Distinct imaging features, including free-floating clots (10.0%) and multiple occlusions (21.2%), were observed.
Conclusions:
- COVID-19 is a systemic disease strongly associated with ATE across all vascular regions, particularly the heart and brain.
- The incidence of ATE in COVID-19 may exceed that of other viral infections.
- ATE in COVID-19 can exhibit unique imaging characteristics and frequently occur within the first week of diagnosis.
Objectives:
Throughout the pandemic, it has become evident that COVID-19 should be recognized as a systemic disease that can affect the coagulation system, potentially resulting in arterial thrombotic events (ATE) with partially bulky free-floating clots. This study aimed to investigate the incidence and imaging characteristics of ATE in hospitalized patients with COVID-19 using clinical and imaging data.
Methods:
From January 2020 to May 2021, databases of five German tertiary care centers were retrospectively screened for COVID-19 patients with coincidental ATE. ATE were analyzed for localization, time of occurrence, imaging characteristics, and associations with clinical data and laboratory parameters.
Results:
Out of 3267 patients, 110 ATE (102 patients, mean age, 72.01 ± 15.64 years; 63 men) were observed in the presence of COVID-19 (3.1%). ATE included ischemic stroke (40%), myocardial infarction (46.4%, %), peripheral infarction (3.6%), thrombi in precerebral arteries (3.6%), mesenteric ischemia (2.7%), thrombi in the aorta (1.8%), splenic infarction (0.9%), and kidney infarction (0.9%). The median time interval between the onset of typical respiratory COVID-19 symptoms and ATE was four days (range, -5-58, negative values indicate ATE prior to symptom onset). A significant percentage of patients exhibited ATEs with an atypical free-floating appearance (10.0%) and multiple occlusions (21.2%).
Conclusion:
COVID-19 is a systemic disease associated with ATE in all vascular regions, with a predilection for the heart and brain. The incidence of ATE might be higher than in comparable viral infections and ATE possibly exhibit distinct imaging features rarely seen, such as bulky free-floating clot masses and multiple occlusions. ATE occur most frequently during the first week around the COVID-19 diagnosis.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction

